The HPV immunisation serves as a protection from a majority of HPV-related cancer forms and genital warts.
Human papillomaviruses (HPV) are viruses, which can infect the cells of the skin and mucosa.
HPV infections are among the most common sexually but also casually transmitted viral diseases. More than 100 different HPV types are known, which are roughly divided into low-risk types and high-risk types.
Low-risk viruses (e.g. HPV6 and 11) are the main causes of genital warts (condyloma); however, they are not potentially life-threatening pathogens.
On the other hand, an infection with a high-risk virus (e.g. HPV 16 and 18) can lead to malignant changes in women and men-for example cervical cancer, anal cancer, vaginal cancer and penile cancer can be traced by to an HPV infection-but also forms of cancer in the throat and pharynx.
The most common type of cancer which is caused by HP viruses in women is cervical cancer-an infection with a high-risk type of HP virus can be diagnosed in the majority of the cases.
However, an HPV infection does not mean that a cancerous disease will certainly develop. In many cases, the immune system can successfully fight the viruses, causing tissue changes to recede.
In other cases, however, the cell changes continue and-via numerous intermediate changes-lead to the formation of cancerous cells.
A possible HPV infection is determined by means of the PAP smear test in the course of the gynaecological examination. If the results are abnormal, the test is repeated-the further procedure (HPV typisation, colposcopy, vaginal ultrasound, biopsy, conisation etc.) depend on the PAP result (group 0, I, II, III, IIID, IIIG, IVa, IVb, V) and are thoroughly discussed as soon as the results are clear.
The HPV immunisation serves as a protection from HPV-related cancer forms and genital warts.
In Austria, a vaccination is approved which immunises against the HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58 (Gardasil 9).
Provided the vaccination is carried out before there is an infection, it offers reliable protection against the respective HPV-strains as well as cross-reactions for other strains. Basically, also vaccinated women should carry out a cancer smear test, so that possible precancerous stages can be detected early.
From July 1st 2023, medicines can be sent via e-prescription (independent of ELGA).
All persons insured in Austria can pick up their medication with a health insurance e-prescription at any Austrian pharmacy - but not at web/online pharmacies! Private prescriptions cannot be sent - they have to be collected at the practice.
As of July 1st 2023, the e-card must be inserted at the practice once per quarter so that the e-prescription is activated for 90 days.
After we received and checked the results we proceed as follows:
1. In case of an urgent result that is subject to treatment we contact you actively and communicate the necessary steps (therapy, appointment, prescription, ...).
2. If you have not heard of us within 2 weeks, you can be assured that your results do not require any further medical clarification or treatment. In this case, even if the result deviates from the reference range, we offer you to ask within your next regular appointment.
Currently we are not able to answer your e-mails regarding that matter due to high influx of e-mails. We kindly ask you for your understanding. Thank you.